These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 11693029)

  • 1. [ACE-dependent and sympathetic components of blood pressure regulation in patients with essential hypertension].
    Aparina TV; Gomazkov OA; Dilakian EA; Britov AN
    Vopr Med Khim; 2001; 47(4):411-8. PubMed ID: 11693029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Moxonidine: a new antiadrenergic antihypertensive agent.
    Prichard BN; Graham BR; Owens CW
    J Hypertens Suppl; 1999 Aug; 17(3):S41-54. PubMed ID: 10489098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. I1-imidazoline-receptor agonists in the treatment of hypertension: an appraisal of clinical experience.
    Ollivier JP; Christen MO
    J Cardiovasc Pharmacol; 1994; 24 Suppl 1():S39-48. PubMed ID: 7533226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective imidazoline agonist moxonidine plus the ACE inhibitor ramipril in hypertensive patients with impaired insulin sensitivity: partners in a successful MARRIAGE?
    Rayner B
    Curr Med Res Opin; 2004 Mar; 20(3):359-67. PubMed ID: 15025845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hypotensive effectiveness of therapy combined enalapril and nitrendipine and influence on the quality of life].
    Bryl W; Cymerys M; Kujawska-Luczak M; Pupek-Musialik D
    Pol Merkur Lekarski; 2005 Mar; 18(105):287-90. PubMed ID: 15997634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autonomic nervous system adjustment (ANSA) in patients with hypertension treated with enalapril.
    Milovanovic B; Trifunovic D; Djuric D
    Acta Physiol Hung; 2011 Mar; 98(1):71-84. PubMed ID: 21388933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective imidazoline agonist moxonidine in obese hypertensive patients.
    Sanjuliani AF; de Abreu VG; Francischetti EA
    Int J Clin Pract; 2006 May; 60(5):621-9. PubMed ID: 16700870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of enalapril maleate on blood pressure, renin-angiotensin-aldosterone system, and peripheral sympathetic activity in essential hypertension.
    Cerasola G; Cottone S; D'Ignoto G; Grasso L; Carone MB; Carapelle E; Contorno A
    Clin Ther; 1987; 9(4):390-9. PubMed ID: 3038326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacology and clinical use of moxonidine, a new centrally acting sympatholytic antihypertensive agent.
    Prichard BN; Owens CW; Graham BR
    J Hum Hypertens; 1997 Aug; 11 Suppl 1():S29-45. PubMed ID: 9321737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effective antihypertensive therapy: blood pressure control with moxonidine.
    Prichard BN; Graham BR
    J Cardiovasc Pharmacol; 1996; 27 Suppl 3():S38-48. PubMed ID: 8872298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Moxonidine in the treatment of overweight and obese patients with the metabolic syndrome: a postmarketing surveillance study.
    Sharma AM; Wagner T; Marsalek P
    J Hum Hypertens; 2004 Sep; 18(9):669-75. PubMed ID: 15269705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of the effectiveness of moxonidine and prestarium in postmenopausal women with mild and moderate arterial hypertension].
    Bakhshaliev AB; Sabzalieva GM
    Klin Med (Mosk); 2006; 84(4):41-4. PubMed ID: 16755855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Placebo-controlled comparison of the efficacy and tolerability of once-daily moxonidine and enalapril in mild-to-moderate essential hypertension.
    Küppers HE; Jäger BA; Luszick JH; Gräve MA; Hughes PR; Kaan EC
    J Hypertens; 1997 Jan; 15(1):93-7. PubMed ID: 9050976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Losartan reduces albuminuria in patients with essential hypertension. An enalapril controlled 3 months study.
    Nielsen S; Dollerup J; Nielsen B; Jensen HA; Mogensen CE
    Nephrol Dial Transplant; 1997; 12 Suppl 2():19-23. PubMed ID: 9269694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of enalapril and telmisartan on clinical and biochemical indices of sympathetic activity in hypertensive patients.
    Lewandowski J; Abramczyk P; Dobosiewicz A; Bidiuk J; Sinski M; Gaciong Z
    Clin Exp Hypertens; 2008 Jul; 30(5):423-32. PubMed ID: 18633764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The comparison of the effect of enalapril and indapamide on the peripheral blood pressure and central blood pressure through pulse wave analysis].
    Jiang XJ; Li QY; Zhang YQ; Liu GZ; Liu LS
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Oct; 33(10):885-8. PubMed ID: 16266472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of effects of enalapril and nitrendipine on cardiac sympathetic nervous system in essential hypertension.
    Sakata K; Shirotani M; Yoshida H; Kurata C
    J Am Coll Cardiol; 1998 Aug; 32(2):438-43. PubMed ID: 9708473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of sympathetic hyperactivity by enalapril in patients with chronic renal failure.
    Ligtenberg G; Blankestijn PJ; Oey PL; Klein IH; Dijkhorst-Oei LT; Boomsma F; Wieneke GH; van Huffelen AC; Koomans HA
    N Engl J Med; 1999 Apr; 340(17):1321-8. PubMed ID: 10219067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin-converting enzyme inhibitors in hypertension: a review.
    Salvetti A; Pedrinelli R; Arzilli F; Abdel-Haq B; Magagna A; Lucarini A; Graziadei L; Nuccorini A; Taddei S
    Int J Clin Pharmacol Res; 1985; 5(6):429-38. PubMed ID: 3005182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [24-hour ambulatory monitoring of blood pressure in patients with essential hypertension: the effectiveness of enalapril therapy].
    Siegelová J; Fiser B; Dusek J
    Vnitr Lek; 1996 Feb; 42(2):98-101. PubMed ID: 8686198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.